Ocular and systemic manifestations of gout

Clinical Eye and Vision Care

Volumn 8, Issue 3, 1996, Pages 155-163

  Burgos, Francisco ^a   Capone, Robert C ^b  

^a Omni Eye Services   (United States)

^b NEW ENGLAND COLLEGE OF OPTOMETRY   (United States)

Author keywords

Acute gouty arthritis; Chronic tophaceous gout; Episcleritis; Gout; Hyperuricemia; Iritis; Podagra; Scleritis; Tophi; Uric acid

Indexed keywords

ALLOPURINOL; ANTIGOUT AGENT; COLCHICINE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROBENECID; URIC ACID;

ARTHRITIS; ARTICLE; CONJUNCTIVA; CONNECTIVE TISSUE; CORNEA; EPISCLERITIS; EYE DISEASE; GOUT; HUMAN; IRITIS; JOINT; POSTMENOPAUSE; SCLERA; SCLERITIS; URIC ACID BLOOD LEVEL;

EID: 0030248387     PISSN: 09534431     EISSN: None     Source Type: Journal    
DOI: 10.1016/0953-4431(96)00176-2     Document Type: Review

References (51)

1. [1] McCarty DJ. Gout and hyperuricemia. J Am Med Assoc 1994;271(4):302-303.
2. [2] Robbins SL, Cotran RS, Kumar V. The musculoskeletal system - gout and gouty arthritis. In: Robbins SL, Contran RS and Kumar V, eds. Pathologic Basis of Disease, 3rd edn. Philadelphia: WB Saunders Co, 1984:1356-1362.
3. [3] Becker MA. Gout and hyperuricemia. In: Stein JH, Daly WJ, Easton DJ, Hutton JJ, et al., eds. Internal Medicine, 2nd edn, Boston: Little, Brown and Co, 1987:1339-1347.
4. [4] Wyngaarden JB, Kelly WN. Drug-induced hyperuricemia and gout. In: Gout and Hyperuricemia. New York: Grune and Stratton Inc. 1976:369-380.
5. [5] Poirier RH. The corneal Limbus. In: Leibowitz HM, ed. Corneal Disorders, Clinical Diagnosis and Management. Philadelphia: WB Saunders Co. 1984:1356-1361.
6. [6] Wyngaarden JB. Disorders of purine and pyrimidine metabolism: gout. In: Wyngaarden JB. Smith LH and Bennett JC, eds. Cecil's Textbook of Medicine, 19th edn, vol. I. Philadelphia: WB Saunders Co, 1992:1107-1115.
7. [7] Jenkins EA, Hallett RJ, Hull RG. Lesch-Nyhan syndrome presenting with renal insufficiency in infants and transient neonatal hypothyroidism. Br J Rheumatol 1994;33(4):392-396.
8. [8] Elliott W. Antihypertensive therapy in a patient with gout and asthma. J Am Med Assoc, Feb 1994 16;(7):555.
9. [9] Gonzalez EB, Miller SB, Agudelo CA. Optimal management of gout in older patients. Drugs Aging 1994;4(2):128-134.
10. [10] Agarwal AK. Gout and pseudogout. Primary Care: Clin Office Pract 1993;20(4):839-855.
11. [11] Kalia KK, Moosy JJ. Carpal tunnel release complicated by acute gout. Neurosurgery 1993;33(6):1102-1103.
12. [12] Lehninger AL. Purine metabolism. In: Lehninger AL, ed. Biochemistry: The Molecular Basis of Cell Structure and Function, 2nd edn. New York: Worth Publishers, 1975:740-746.
13. [13] Rosenberg AE. Skeletal system and soft tissue tumors. In: Contran RS, Kumar V and Robbins SL, eds. Robbin's Pathologic Basis of Disease, 5th edn. Philadelphia: WB Saunders Co, 1994:1213-1259.
14. [14] Wyngaarden JB, Kelly WN. Clinical syndromes associated with hypoxanthine-guanine phosphoribosyl transferase deficiency. In: Wyngaarden JB and Kelly WN, eds. Gout and Hyperuricemia. New York: Grune and Stratton Inc, 1976:309-344.
15. [15] VanLieshout-Zuidema HF, Breedveld FC. Withdrawal of longterm antihyperuricemic therapy in tophaceous gout. J Rheumatol 1993;2(8):1383-1385.
16. [16] Cormack DH. Ham's Histology, 9th edn. Philadelphia: JB Lippincott, 1987;101-102.
17. [17] Verburch CA, Hart MHL, Arden LA, et al. Interleukin-8 (IL-8) in synovial fluid of rheumatoid and non-rheumatoid joint effusion. Clin Rheumatol 1993;12(4):494-499.
18. [18] Gaines DR. Tophaceous gout. An unusual presentation. J Am Podiatr Med Assoc 1993;83(11):652-653.
19. [19] Ifudo O, Tan C, Dulin A, et al. Gouty arthritis in end stage renal disease: Clinical course and rarity of new cases. Am J Kidney Dis 1994;23(3):347-351.
20. [20] Gagliardi JA, Lengyel RL. A review of the radiographic manifestations of gout. Hawaii Med J 1994;53:40-43.
21. [21] Ferry AP, Safir A, Harrout EM. Ocular manifestations in patients with gout. Ann Ophthalmol 1985;17:632-635.
22. [22] Friedlaender MH. Metabolic disease. In: Smolin G and Thoft RA, eds. The Cornea, 2nd edn. Boston: Little, Brown and Co, 1987:475-479.
23. [23] Slansky HH, Kuwabara T. Intranuclear urate crystals in corneal epithelium. Arch Opthalmol 1968;80:338-344.
24. [24] McWilliam JR. Ocular findings in gout: Report of a conjunctival tophi. Am J Ophthalmol 1952;35:1778-1783.
25. [25] Volcker HE, Naumann GOH. Conjunctiva. In: Naumann GOH and Apple DJ, eds. Pathology of the Eye, 1st edn. New York: Springer-Verlag, 1986:269-273.
26. [26] Arffa RC, Eve FR. Systemic associations of corneal deposits. Int Ophthalmol Clin 1991;31-33,89-108.
27. [27] Fishman RS, Sunderman FW. Band keratopathy in gout. Arch Ophthalmol 1966;75:367-369.
28. [28] Schwab IR, Dawson CR. Conjunctiva. In: Vaughan D, Asbury T and Riordan-Eva P, eds. General Ophthalmology, 13th edn. Norwalk: Appleton & Lange, 1992:96-124.
29. [29] Ferry AP. Gout. In: Gold DH and Weingeist TA, eds. The Eye in Systemic Disease. Philadelphia: JB Lippincott Co, 1988:396-398.
30. [30] Watson PG. Episcleritis. In: Fraunfelder FT, Roy FH and Grove J, Assoc. eds. Current Ocular Therapy 4. Philadelphia: WB Saunders, 1995:809-811.
31. [31] Martinez-Cordero E, Barreira-Mercado E, Katona G. Eye tophi deposition in gout (letter). J Rheumatol 1986;13(2):471-473.
32. [32] Safir A, Dunn SN, Martin RG, et al. Is asteroid hyalosis ocular gout? Ann Ophthalmol 1990;22:70-77.
33. [33] Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
34. [34] Beutler A, Schumacher HR. Gout and pseudogout. When are arthritic symptoms caused by crystal deposition? Postgrad Med, Feb. 1994;103-106,109,113-116.
35. [35] Ho G Jr, DeNuccio M. Gout and pseudogout in hospitalized patients. Arch Int Med 1993;153(24):2787-2790.
36. [36] Rogachefsky RA, Carneiro R, Aitman RD. Gout presenting as infectious arthritis. Two case reports. J Bone Joint Surg Am, Feb 1994;76(2):269-273.
37. [37] Sharma A, Buethque BA, Smith EB. Gout masquerading as rheumatoid vasculitis. J Rheumatol 1994;21(2):368-369.
38. [38] Schumacher Jr. HR. Crystal deposition arthropathies. In: Wyngaarden JB, Smith LH and Bennett JC, eds. Cecil's Textbook of Medicine, 19th edn, Vol. 2. Philadelphia: WB Saunders Co, 1992:1552-1554.
39. [39] Lewing G. Preventing acute gout when starting allopurinol therapy: Colchicine or NSAIDS? Med J Aust 1993;159(11-12):833-834.
40. [40] Ferraz MB, Sato EI, Nishie IA. A survey of prescribing practices in gouty arthritis and asymptomatic hyperuricemia in Sao Paulo, Brazil. J Rheumatol 1994;21(2):374-375.
41. [41] Vedia C, Mascort JJ. Colchicine and thrombopenia (letter). Exp Rheumatol, Jul-Aug 1993;11(4):458.
42. [42] Shlondorff D. Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int, Sept 1993;44(3):643-653.
43. [43] Emmerson BT. The management of gout. N Engl J Med, Feb 1996;334:445-451.
44. [44] Wilkins JH. Gout (Hyperuricemia). In: Fraunfelder FT, Roy FH and Grove J, Assoc. eds. Current Ocular Therapy 4. Philadelphia: WB Saunders, 1995:183-185.
45. [45] Clark WG, Brater DG, Johnson AR. Non-steroidal anti-inflammatory antipyretic analgesics. In: Easton WG, Brater DG and Johnson AR, eds. Goth's Medical Pharmacology, 13th edn. St Louis: Mosby Year Book, 1992:356-373.
46. [46] Lerman S. Gout (Hyperuricemia). In: Fraunfelder FT, Roy FH and Meyer MS, Assoc. eds. Current Ocular Therapy 3. Philadelphia: WB Saunders, 1990:160-163.
47. [47] Hanger HC. Death following allopurinol hypersensitivity syndrome. N Z Med J 1994;107(979):229.
48. [48] Liu CSC, Brown AP, Leonard TJK et al. The prevalence and morphology of cataract in patients on allopurinol treatment. Eye 1988;2:600-606.
49. [49] Fraunfelder FT, Hanna C, Dreis MW, et al. Cataracts associated with allopurinol therapy. Am J Ophthalmol, 1982;94(2):137-140.
50. [50] Pavan-Langsten D, Dunkel EC. Analgesics and antiarthritics. In: Pavan-Langston D and Dunkel EC, eds. Handbook of Ocular Drug Therapy and Ocular Side Effects of Systemic Drugs, 1st edn. Boston: Little, Brown and Co, 1991:243-253.
51. [51] Burton BT, Foster WR. Nutrition and diet in gout and osteoarthritis. In: Burton BT and Foster WR, eds. Human Nutrition, 4th edn. New York: McGraw-Hill Book Co, 1988:428-434.